MedicarePartD.guide

A non-government resource built from CMS public data

Biologics for severe asthma and COPD on Prescription Blue Premium (S5584-002)

Dupixent, Nucala, Fasenra and Xolair, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Michigan
Premium
$106.70/month
Deductible
None
Change plan

4 of 4 Asthma and COPD biologics are covered on this plan. All 4 require prior authorization.

  • Dupixent
    dupilumab
    Covered · prior auth
    from $2,919.46
    Tier 5
  • Nucala
    mepolizumab
    Covered · prior auth
    33%
    Tier 5
  • Fasenra
    benralizumab
    Covered · prior auth
    33%
    Tier 5
  • Xolair
    omalizumab
    Covered · prior auth
    33%
    Tier 5

Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list